Galanin Receptor Subtype GalR2 Mediates Apoptosis in SH-SY5Y Neuroblastoma Cells
Open Access
- 1 February 2004
- journal article
- other
- Published by The Endocrine Society in Endocrinology
- Vol. 145 (2) , 500-507
Abstract
Recently we have shown that galanin binding significantly correlates with survival in neuroblastoma patients, indicating a possible modulatory role of galanin receptors in neuroblastic tumor biology. However, the molecular mechanisms beyond this correlation have not been elucidated. Here, the cellular effects on activation of specific galanin receptor subtypes in human SH-SY5Y neuroblastoma cells were analyzed using a tetracycline-controlled expression system. Pharmacological studies confirmed the inducible expression of high affinity binding sites for galanin in SH-SY5Y cells transfected with the galanin receptors GalR1 (SY5Y/GalR1) and GalR2 (SY5Y/GalR2). Microphysiometry revealed that both receptor subtypes were able to mediate an intracellular signal upon galanin application. Interestingly, induction of receptor expression and treatment with 100 nm galanin resulted in a dramatic decrease in cell viability in SY5Y/GalR2 cells (93 ± 3%) compared with a less pronounced effect in SY5Y/GalR1 cells (19 ± 10%). The antiproliferative potency of galanin was 100-fold higher in SY5Y/GalR2 (50% effective concentration, 1.1 nm) than in SY5Y/GalR1 cells (50% effective concentration, 190 nm). Furthermore, activation of receptor expression and exposure to galanin resulted in apparent morphological changes indicative of apoptosis in SY5Y/GalR2 cells only. Induction of cell death by the apoptotic process was confirmed by poly-(ADP-ribose)-polymerase cleavage, caspase-3 activation, and the typical laddering of DNA. This study indicates that a high level of GalR2 expression is able to inhibit cell proliferation and induce apoptosis in neuroblastoma cells and therefore identifies GalR2 as a possible target for pharmacological intervention in neuroblastoma.Keywords
This publication has 30 references indexed in Scilit:
- Galanin and galanin receptors in human gliomasActa Neuropathologica, 2003
- Galanin in human pituitary adenomas: frequency and clinical significanceClinical Endocrinology, 2002
- Biphasic response to human galanin of extracellular acidification in human Bowes melanoma cellsEuropean Journal of Pharmacology, 2001
- Galanin receptor subtypesTrends in Pharmacological Sciences, 2000
- Isolation and cDNA Cloning of a Novel Galanin-like Peptide (GALP) from Porcine HypothalamusJournal of Biological Chemistry, 1999
- Galanin and Galanin Receptors1999
- Galanin receptors from human pituitary tumors assayed with human galanin as ligandBrain Research, 1993
- Galanin immunoreactivity in the primate central nervous systemJournal of Comparative Neurology, 1992
- Presence of Galanin-Like Immunoreactivity in Nontumorous Corticotrophs and Corticotroph Adenomas of the Human PituitaryThe Journal of Clinical Endocrinology & Metabolism, 1990
- Galanin — a novel biologically active peptide from porcine intestineFEBS Letters, 1983